A Potential Role for the CDH13/CDH15 Gene in Repeat Revascularization After First Percutaneous Coronary Intervention

References

• Li J , LiX , WangQet al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet385, 441–451 (2015).
   PubMed Web of Science ®Google Scholar
• Weintraub WS , Grau-SepulvedaMV , WeissJMet al. Prediction of long-term mortality after percutaneous coronary intervention in older adults results from the National Cardiovascular Data Registry. Circulation125, 1501–1510 (2012).
   PubMedGoogle Scholar
• Chen W-W , GaoR-L , LiuL-Set al. 2017-Cardiovascular disease report in China – outline. Chin. Circ. J.33(1), 1–8 (2018).
   Google Scholar
• Roiron C , SanchezP , BouzamondoAet al. Drug eluting stents: an updated meta-analysis of randomized controlled trials. Heart92, 641–649 (2006).
   PubMed Web of Science ®Google Scholar
• Authors/Task Force members , WindeckerS , KolhPet al.2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J.35(37), 2541–2619 (2014).
   PubMed Web of Science ®Google Scholar
• Jukema JW , VerschurenJJ , AhmedTAet al. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat. Rev. Cardiol.9, 53–62 (2012).
   Web of Science ®Google Scholar
• Sampietro ML , PonsD , de KnijffP , SlagboomPE , ZwindermanA , JukemaJW. A genome wide association analysis in the GENDER study. Neth. Heart J.17(6), 262–264 (2009).
   PubMed Web of Science ®Google Scholar
• Miao HW , GongH. Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: a meta-analysis. J. Renin Angiotensin Aldosterone Syst.16(4), 844–850 (2015).
   PubMed Web of Science ®Google Scholar
• Ma W , LiangY , ZhuJet al. Relationship of paraoxonase-1 Q192R genotypes and in-stent restenosis and re-stenting in Chinese patients after coronary stenting. Atherosclerosis251, 305–310 (2016).
   PubMed Web of Science ®Google Scholar
• Verschuren JJ , SampietroML , PonsDet al. Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis? Dis. Markers 29(5), 265–273 (2010).
   PubMed Web of Science ®Google Scholar
• Schulz S , SibbingD , BraunSet al. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. Am. Heart J.160(2), 355–361 (2010).
   PubMed Web of Science ®Google Scholar
• Howie B , FuchsbergerC , StephensMet al. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet.44(8), 955–959 (2012).
   PubMed Web of Science ®Google Scholar
• 1000 Genomes Project Consortium , AutonA , BrooksLDet al.A global reference for human genetic variation. Nature526(7571), 68–74 (2015).
   PubMed Web of Science ®Google Scholar
• GTEx . www.gtexportal.org/home/gene/
   Google Scholar
• Verschuren JJ , TrompetS , SampietroMLet al. Pathway analysis using genome-wide association study data for coronary restenosis – a potential role for the PARVB gene. PLoS ONE8(8), e70676 (2013).
   PubMed Web of Science ®Google Scholar
• Bhalla K , LuoY , BuchanTet al. Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability. Am. J. Hum. Genet.83(6), 703–713 (2008).
   PubMed Web of Science ®Google Scholar
• Frismantiene A , PfaffD , FrachetAet al. Regulation of contractile signaling and matrix remodeling by T-cadherin in vascular smooth muscle cells: constitutive and insulin-dependent effects. Cell. Signal.26(9), 1897–908 (2014).
   PubMed Web of Science ®Google Scholar
• Takeuchi T , AdachiY , OhtsukiYet al. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med. Mol. Morphol.40(3), 115–120 (2007).
   PubMed Web of Science ®Google Scholar
• Org E , EyheramendyS , JuhansonPet al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum. Mol. Genet.18(12), 2288–2296 (2009).
   PubMed Web of Science ®Google Scholar
• Chung CM , LinTH , ChenJWet al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes60(9), 2417–2423 (2011).
   PubMed Web of Science ®Google Scholar
• Gao H , KimYM , ChenPet al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in east Asian populations. Diabetes62(12), 4277–4283 (2013).
   PubMed Web of Science ®Google Scholar
• de Maat MP , JukemaJW , YeSet al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am. J. Cardiol.83(6), 852–856 (1999).
   PubMed Web of Science ®Google Scholar
• Humphries S , BautersC , MeirhaegheAet al. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur. Heart J.23(9), 721–725 (2002).
   PubMed Web of Science ®Google Scholar
• Hoppmann P , KochW , SchomigAet al. The 5A/6Apolymorphismofthestromelysin-1geneandrestenosis after percutaneous coronary interventions. Eur. Heart J.25, 335–341 (2004).
   PubMedGoogle Scholar
• Verschuren JJ , SampietroML , PonsDet al. Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis? Dis. Markers 29(5), 265–273 (2010).
   PubMed Web of Science ®Google Scholar
• Giustino G , BaberU , SartoriSet al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol.65(13), 1298–1310 (2015).
   PubMed Web of Science ®Google Scholar